Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published

Ciro Manzo1, Marco Isetta2, Alberto Castagna3

  • 1Department of Internal and Geriatric Medicine, Azienda Sanitaria Locale Napoli 3 sud, Rheumatologic Outpatient Clinic, Health District No. 59, Naples, Sant'Agnello, Italy.

Reumatologia
|December 16, 2024
PubMed
Abstract

Insights

The exact cause of polymyalgia rheumatica (PMR) remains unknown, with current research suggesting infections may play a role, though a definitive link is not established. Genetic and epigenetic factors are likely important in PMR development.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Genetics

Background:

  • The etiology of polymyalgia rheumatica (PMR) is currently unknown.
  • Recent reports suggest a potential link between PMR and coronavirus disease 2019 (COVID-19), reviving interest in infections as triggers.
  • Giant cell arteritis (GCA) co-occurs with PMR in less than 20% of cases, with limited understanding of infectious agents' role in this association.

Purpose of the Study:

  • To review and discuss the relationship between PMR and infectious agents.
  • To compare infectious agents in PMR-only patients versus those with PMR and overlapping GCA.

Main Methods:

  • A non-systematic literature search was conducted on Embase and Medline using terms like "polymyalgia rheumatica" and "infections."
  • Reference lists of relevant papers were scanned for additional studies.
  • Exclusion criteria included conference abstracts, non-peer-reviewed sources, and PMR following vaccinations.

Main Results:

  • Several infectious agents have been implicated in PMR, but no definitive causal link has been established.
  • The search for a specific infectious agent appears to be stagnating, with genetic and epigenetic factors likely playing a significant role.
  • PMR following immunization requires methodological distinction from PMR post-infection due to vaccine adjuvants.

Conclusions:

  • While some infectious agents can theoretically trigger GCA, their role in isolated PMR appears minimal.
  • The specific role of infectious agents in the etiology of PMR and its association with GCA requires further investigation.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
642